M. S. Bakir Et Al. , "The effect of bevacizumab maintenance therapy on survival in recurrent epithelial ovarian cancer," EUROPEAN JOURNAL OF GYNAECOLOGICAL ONCOLOGY , vol.42, no.6, pp.1198-1204, 2021
Bakir, M. S. Et Al. 2021. The effect of bevacizumab maintenance therapy on survival in recurrent epithelial ovarian cancer. EUROPEAN JOURNAL OF GYNAECOLOGICAL ONCOLOGY , vol.42, no.6 , 1198-1204.
Bakir, M. S., BİRGE, Ö., KARADAĞ, C., DOĞAN, S., TUNCER, H. A., & ŞİMŞEK, T., (2021). The effect of bevacizumab maintenance therapy on survival in recurrent epithelial ovarian cancer. EUROPEAN JOURNAL OF GYNAECOLOGICAL ONCOLOGY , vol.42, no.6, 1198-1204.
Bakir, MEHMET Et Al. "The effect of bevacizumab maintenance therapy on survival in recurrent epithelial ovarian cancer," EUROPEAN JOURNAL OF GYNAECOLOGICAL ONCOLOGY , vol.42, no.6, 1198-1204, 2021
Bakir, MEHMET S. Et Al. "The effect of bevacizumab maintenance therapy on survival in recurrent epithelial ovarian cancer." EUROPEAN JOURNAL OF GYNAECOLOGICAL ONCOLOGY , vol.42, no.6, pp.1198-1204, 2021
Bakir, M. S. Et Al. (2021) . "The effect of bevacizumab maintenance therapy on survival in recurrent epithelial ovarian cancer." EUROPEAN JOURNAL OF GYNAECOLOGICAL ONCOLOGY , vol.42, no.6, pp.1198-1204.
@article{article, author={MEHMET SAİT BAKIR Et Al. }, title={The effect of bevacizumab maintenance therapy on survival in recurrent epithelial ovarian cancer}, journal={EUROPEAN JOURNAL OF GYNAECOLOGICAL ONCOLOGY}, year=2021, pages={1198-1204} }